21 May 2009
The lipid profile of the living kidney donors
M Bieniasz, A Kwiatkowski, J Gozdowska, R Kieszek, P Domagała, A Darocha, J Trzebicki, M Durlik, L Pączek, A ChmuraAnn Transplant 2009; 14(1): 50-50 :: ID: 880383
Abstract
Background: Living kidney donation is becoming more significant as the
number of cadaveric transplants remains fairly constant and outcome does
not improve due to accumulation of aged patients with a long time on dialysis. Only 2-3% of kidney transplants in Poland come from the living donors. Lipid profiles of the living donors need to be evaluated in order to stratify cardiovascular risk before donation. The aim of this study was to assess the lipid profile of living kidney donors.
Material/Methods: Between 1995 and 2005, 66 living donor open nephrectomies were performed. Physical examination, blood and urine tests were performed prior to nephrectomy and at every follow-up visit (36 months and every 12 months post-op). Donor mean age was 40.9 years (range 29-60). There were 21 women and 18 men. 27 donors did not report for follow-up visits. Observation period ranged from 36 to 156 months. Hypercholesterolemia was defined as total cholesterol concentration >200 mg/dl. Hypertrigyceridemia was defined as triglycerides concentration 150 mg/dl.
Results: Hyperlipidaemia was present in 3 (7.7%) donors prior to surgery.
22 (56.4%) patients developed hyperlipidaemia after donation. Appropriate
treatment was initiated for hyperlipidaemia in the diagnosed patients. 15 patients had mild hyperlipidaemia treated by diet modification and 7 patients needed statin administration. No cases of diabetes mellitus were observed.
Conclusions: Follow-up of living kidney donors' lipid profile should be included in the work-up as prevention of cardiovascular disease.
Keywords: Kidney Transplantation, Living Donors
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






